| Literature DB >> 33579598 |
Glória Maria de França1, Fernanda Aragão Felix2, Everton Freitas de Morais3, Maurília Raquel de Souto Medeiros3, Ana Cláudia de Macedo Andrade3, Hébel Cavalcanti Galvão3.
Abstract
INTRODUCTION: Pycnodysostosis is a rare autosomal recessive syndrome that provides the abnormal bone metabolism that increases the susceptibility of patients to develop osteomyelitis.Entities:
Keywords: Cathepsin K; Diagnosis; Jaws; Osteomyelitis; Pycnodysostosis
Mesh:
Year: 2021 PMID: 33579598 PMCID: PMC9422419 DOI: 10.1016/j.bjorl.2020.12.009
Source DB: PubMed Journal: Braz J Otorhinolaryngol ISSN: 1808-8686
Figure 1Flow chart of the database search and article selection process according to PRISMA.
Quality assessment to CARE checklist.
| Topic | Item | Description | Percentage of case reports |
|---|---|---|---|
| Title | 1 | The words “case report” should be in the title along with the area of focus | 7 |
| Keywords | 2 | 2 to 5 keywords that identify areas covered in this case report | 10 |
| Abstract | 3a | Introduction – What is unique about this case? What does it add to the medical literature? | 5 |
| 3b | The main symptoms of the patient and the important clinical findings | 6 | |
| 3c | The main diagnoses, therapeutics interventions, and outcomes | 6 | |
| 3d | Conclusion – What are the main “take-away” lessons from this case? | 5 | |
| Introduction | 4 | One or two paragraphs summarizing why this case is unique with references. | 17 |
| Patient information | 5a | De-identified demographic information and other patient specific information. | 13 |
| 5b | Main concerns and symptoms of the patient. | 16 | |
| 5c | Medical, family, and psychosocial history including relevant genetic information (also see timeline) | 15 | |
| 5d | Relevant past interventions and their outcomes | 13 | |
| Clinical findings | 6 | Describe the relevant Physical Examination (PE) and other significant clinical findings. | 20 |
| Timeline | 7 | Important information from the patient’s history organized as a timeline | 16 |
| Diagnostic assessment | 8a | Diagnostic methods (such as PE, laboratory testing, imaging, surveys) | 17 |
| 8b | Diagnostic challenges (such as access, financial, or cultural) | 1 | |
| 8c | Diagnostic reasoning including other diagnoses considered | 1 | |
| 8d | Prognostic characteristics (such as staging in oncology) where applicable | 0 | |
| Therapeutic intervention | 9a | Types of intervention (such as pharmacologic, surgical, preventive, self-care) | 18 |
| 9b | Administration of intervention (such as dosage, strength, duration) | 10 | |
| 9c | Changes in intervention (with rationale) | 2 | |
| Follow-up and outcomes | 10a | Clinician and patient-assessed outcomes (when appropriate) | 13 |
| 10b | Important follow-up diagnostic and other test results | 9 | |
| 10c | Intervention adherence and tolerability (How was this assessed?) | 4 | |
| 10d | Adverse and unanticipated events | 4 | |
| Discussion | 11a | Discussion of the strengths and limitations in your approach to this case | 4 |
| 11b | Discussion of the relevant medical literature | 13 | |
| 11c | The rationale for conclusions (including assessment of possible causes) | 13 | |
| 11d | The primary “take-away” lessons of this case report | 3 | |
| Patient perspective | 12 | When appropriate the patient should share their perspective on the treatments, they received | 3 |
Etiology, Clinical and radiographic characteristics of the 27 cases of osteomyelites in patients with pycnodysostosis.
| Parameters | n | % |
|---|---|---|
| Nº de casos | 26 | 100.0 |
| Age | ||
| Range | 21–55 years old | |
| Media | 37.84 | |
| Standard deviation | 9.58 | |
| Gender | ||
| Female | 11 | 42.3 |
| Male | 15 | 57.7 |
| Family history | ||
| Consanguineous marriage | 4 | 15.4 |
| Siblings | 6 | 23.0 |
| Aunt | 1 | 3.8 |
| No family history | 6 | 23.0 |
| NA | 11 | 42.3 |
| Medical history | ||
| Fractures of the long bones | 9 | 34.6 |
| Femoral fracture | 4 | 15.4 |
| Tibial fractures | 3 | 11.5 |
| Elbows | 3 | 11.5 |
| Rib | 2 | 7.7 |
| Hip | 2 | 7.7 |
| Clavicle | 1 | 3.8 |
| Shoulder blade | 1 | 3.8 |
| Knee | 1 | 3.8 |
| Hydrocephalus | 2 | 7.7 |
| NA | 7 | 26.9 |
| Promoter factor | ||
| Tooth exodontics | 16 | 61.5 |
| Jaw fracture | 6 | 23.0 |
| Carie | 3 | 11.5 |
| Periodontal disease | 3 | 11.5 |
| Carie and periodontal disease | 1 | 3.8 |
| Anatomical location | ||
| Maxila | 4 | 15.4 |
| Mandíbula | 20 | 76.9 |
| Maxila e mandíbula | 2 | 7.7 |
| Symptomatology | ||
| Swelling | 12 | 46.1 |
| Pain | 11 | 42.3 |
| Purulent secretion | 9 | 34.6 |
| Fistula | 5 | 19.2 |
| Trismus | 1 | 3.8 |
| No symptomatology | 1 | 3.8 |
| NA | 2 | 7.7 |
| Radiographic features | ||
| Sequestrum | 16 | 61.5 |
| Osteolysis | 7 | 26.9 |
| Radiolucence | 2 | 7.7 |
| Poorly defined edges | 2 | 7.7 |
| Osteosclerosis | 11 | 42.3 |
| Jaw fracture | 4 | 15.4 |
| Hipercementosis | 3 | 11.5 |
| Treatment | ||
| Antibiotic therapy | 21 | 80.7 |
| Sequestrectomy | 14 | 53.8 |
| Curettage | 8 | 30.7 |
| Tooth extraction | 4 | 15.4 |
| Resection | 2 | 7.7 |
| Jaw reconstruction | 5 | 19.2 |
| NA | 1 | 3.8 |
| Follow-up | ||
| Present in | 17 | 65.4 |
| Range | 6–168 months | |
| Media | 28.46 | |
| Standard deviation | 39.80 | |
| NA | 9 | 34.6 |
NA, Not available.
Patients present more than one category in the group.
Figure 2Causes of osteomyelitis in patients with pycnodysostosis.
Figure 3Etiology of osteomyelitis in patients with pycnodysostosis. (A) Osteoclasts release H + and cathepsin K into How ship lacunae during tooth extraction in patients with normal bone density. (B) After bone resorption, osteoblasts are attracted to the site and initiate the process of bone neoformation. (C) Newly formed bone. (D) In the absence of cathepsin K, osteoclasts act inefficiently, leading to acid medium. Patients with osteosclerosis are more susceptible to fractures in response to small traumas because of reduced bone vascularization. (E) The presence of microorganisms, the acid medium and the impairment of bone turnover cause the formation of bone sequestrum. (F) Caries and periodontal disease induce the release of inflammatory mediators and microbial products and associated with impaired osteoclast activity, promote osteomyelitis in patients with pycnodysostosis.